鸡冠花综述:传统应用、化学成分、药理、毒理与质量控制及网络药理学分析
鸡冠花在中国药用逾千年,临床用于崩漏、带下及胃肠道感染等。本综述汇总其植物学、传统应用、化学成分、药理、安全性与质量控制,并纳入网络药理学初步分析。
要点
- 鸡冠花传统用于崩漏、带下及胃肠道感染,临床报道对功能性子宫出血、阴道炎和盆腔炎有效。
- 需寻找鸡冠花特征性成分并建立更优质量控制标准,以进一步挖掘治疗潜力。
核心结论
- 鸡冠花在止血、抗炎和抗微生物治疗方面显示显著潜力。
- 现代研究揭示其多样化学成分和药理活性,具有较高研究价值,但需建立更好质控标准以探索治疗潜力。
研究设计与样本
- 综述类研究,检索范围包括《中国药典》《中国植物志》及Web of Science、CAS CiFinder、PubMed、Science Direct、CNKI等数据库和众多古代本草经典。
主要发现
- 药理研究显示止血、抗滴虫、抗菌、抗病毒、镇痛、免疫调节、抗炎、抗癌、保肝和抗氧化等活性。
- 临床应用显示对功能性子宫出血、阴道炎和盆腔炎有效。
- 利用网络药理学初步探究了化学成分、分子靶标与病理状态之间的相互作用。
临床怎么用
- 可关注鸡冠花在崩漏、带下及胃肠道感染等传统适应症中的潜在应用。
- 临床应用时应结合其止血、抗炎、抗菌等药理活性,并注意现有研究对质控标准的提示。
局限性
- 需寻找鸡冠花特征性成分并建立更好的质量控制标准。
- 当代研究存在普遍挑战与局限,需进一步深入探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Celosia cristata L. (C. cristata) is a widely used herb in China and has been used as a medicine for more than 1000 years. The herb has been clinically employed to treat various types of bleeding disorders including metrorrhagia, metrostaxis, and leukorrheal diseases, gastrointestinal infections. AIM OF THE STUDY: This review provides a comprehensive analysis of C. cristata, encompassing its botany, traditional applications, phytochemistry, pharmacology, safety, and quality control. Additionally, it delves into the prevailing challenges and limitations with contemporary research concerning C. cristata, thus furnishing valuable insights for future investigations in this domain. MATERIALS AND METHODS: Research data were gathered from authoritative sources including the Pharmacopoeia of China, the Flora of China, as well as various internet databases such as Web of Science, CAS CiFinder, PubMed, Science Direct, and CNKI, along with numerous ancient classics on Chinese herbal medicine. RESULTS: Clinical applications of C. cristata demonstrate its efficacy in treating dysfunctional uterine bleeding, vaginitis, and pelvic inflammatory disease. Presently, seventy-seven compounds have been isolated, including flavonoids, triterpenoids, steroids, organic acids, phenylpropanoids, and alkaloids, with flavonoids and triterpenoids emerging as the primary bioactive constituents. Pharmacological studies reveal its diverse biological activities, such as haemostatic, antitrichomonal, antibacterial, antiviral, analgesic, immunoregulatory, anti-inflammatory, anticancer, hepatoprotective, and antioxidant effects. Leveraging network pharmacology, researchers have embarked on preliminary inquiries into the interplay among chemical constituents, molecular targets and pathological conditions. CONCLUSIONS: C. cristata shows significant potential for use in hemostasis, anti-inflammatory, and antimicrobial treatments. Modern research has revealed its diverse chemical composition and pharmacological activities, making it highly valuable for further study. At the same time, it is necessary to find the characteristic components of C. cristata and establish better quality control standards to better explore its therapeutic potential.
引用
- Luo Y, Xu Y, Zhang H, et al. Celosia cristata L.: A review of its traditional uses, phytochemistry, pharmacology, toxicology, and quality control, along with network pharmacological analysis of its components and targets. J Ethnopharmacol. 2024. PMID: 38740106. doi:10.1016/j.jep.2024.118325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。